PUBLICATION

Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish

Authors
Kokel, D., and Peterson, R.T.
ID
ZDB-PUB-080915-15
Date
2008
Source
Briefings in functional genomics & proteomics   7(6): 483-490 (Review)
Registered Authors
Peterson, Randall
Keywords
phenomics, chemical genetics, zebrafish
MeSH Terms
  • Animals
  • Antipsychotic Agents/pharmacology*
  • Behavior, Animal/drug effects*
  • Drug Discovery*
  • Zebrafish/physiology*
PubMed
18784194 Full text @ Brief. Funct. Genomic. Proteomic.
Abstract
Despite their ubiquity and impact, psychiatric illnesses and other disorders of the central nervous system remain among the most poorly treated diseases. Most psychiatric medicines were discovered due to serendipitous observations of behavioural phenotypes in humans, rodents and other mammals. Extensive behaviour-based chemical screens would likely identify novel psychiatric drugs. However, large-scale chemical screens in mammals are inefficient and impractical. In contrast, zebrafish are very well suited for high-throughput behaviour-based drug discovery. Furthermore, the vast amounts of data generated from large-scale behavioural screens in zebrafish will facilitate a systems-level analysis of how chemicals affect behaviour. Unlike serendipitous discoveries in mammals, a comprehensive and integrative analysis of zebrafish chemobehavioural phenomics may identify functional relationships that would be missed by more reductionist approaches. Thus, behaviour-based chemical screens in the zebrafish may improve our understanding of neurobiology and accelerate the pace of psychiatric drug discovery.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping